|Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers|
J Park, J Lee, C Choi*
PLoS ONE 6 (8), e23211, 2011
|Human glioblastoma arises from subventricular zone cells with low-level driver mutations|
JH Lee, JE Lee, JY Kahng, SH Kim, JS Park, SJ Yoon, JY Um, WK Kim, ...
Nature 560 (7717), 243-247, 2018
|Hepatitis C virus infection enhances TNFα‐induced cell death via suppression of NF‐κB|
J Park, W Kang, SW Ryu, WI Kim, DY Chang, DH Lee, DY Park, YH Choi, ...
Hepatology 56 (3), 831-840, 2012
|Phenotypic modulation of primary vascular smooth muscle cells by short-term culture on micropatterned substrate|
S Chang, S Song, J Lee, J Yoon, J Park, S Choi, JK Park, K Choi*, ...
PLoS ONE 9 (2), e88089, 2014
|SoxF transcription factors are positive feedback regulators of VEGF signaling|
K Kim, IK Kim, JM Yang, E Lee, BI Koh, S Song, J Park, S Lee, C Choi, ...
Circulation Research 119 (7), 839-852, 2016
|The mode and dynamics of glioblastoma cell invasion into a decellularized tissue-derived extracellular matrix-based three-dimensional tumor model|
IK Koh, J Cha, J Park, J Choi, SG Kang*, P Kim*
Scientific Reports 8 (1), 4608, 2018
|Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin|
EH Kim, JH Lee, Y Oh, I Koh, JK Shim, J Park, J Choi, M Yun, JY Jeon, ...
Neuro-Oncology 19 (2), 197-207, 2017
|Contribution of mitochondrial network dynamics to intracellular ROS signaling|
J Park, C Choi*
Communicative & Integrative Biology 5 (1), 81-83, 2012
|Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres|
J Park, JK Shim, JH Kang, J Choi, JH Chang, SY Kim*, SG Kang*
Neuro-Oncology 20 (7), 954-965, 2018
|Constitutive expression of MAP kinase phosphatase-1 confers multi-drug resistance in human glioblastoma cells|
H Yu", J Park", J Lee, K Choi, C Choi*
Cancer Research and Treatment 44 (3), 195-201, 2012
|Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)|
J Choi, JH Lee, I Koh, JK Shim, J Park, JY Jeon, M Yun, SH Kim, JI Yook, ...
Oncotarget 7 (40), 65643-65659, 2016
|TGF-β1 and hypoxia-dependent expression of MKP-1 leads tumor resistance to death receptor-mediated cell death|
J Park, J Lee, W Kang, S Chang, EC Shin, C Choi*
Cell Death & Disease 4 (2), e521, 2013
|Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments|
KM Kim, JK Shim, JH Chang, JH Lee, SH Kim, J Choi, J Park, EH Kim, ...
Cancer Cell International 16, 43, 2016
|Application of femtosecond‐pulsed lasers for direct optical manipulation of biological functions|
J Yoon, J Park, M Choi, W Jong Choi, C Choi*
Annalen der Physik 525 (3), 205-214, 2012
|Histopathological implications of ventricle wall 5-aminolevulinic acid-induced fluorescence in the absence of tumor involvement on magnetic resonance images|
JH Moon, SH Kim, JK Shim, TH Roh, KS Sung, JH Lee, J Park, J Choi, ...
Oncology Reports 36 (2), 837-844, 2016
|Isolation and characterization of tumorspheres from a recurrent pineoblastoma patient: Feasibility of a patient-derived xenograft|
J Kwak, JK Shim, DS Kim, JH Lee, J Choi, J Park, KJ Shin, SH Kim, P Kim, ...
International Journal of Oncology 49 (2), 569-578, 2016
|Evaluation of drug-targetable genes by defining modes of abnormality in gene expression|
J Park*, J Lee, C Choi*
Scientific Reports 5, 13576, 2015
|Mutant ubiquitin attenuates interleukin-1β-and tumor necrosis factor-α-induced pro-inflammatory signaling in human astrocytic cells|
K Choi, J Park, J Lee, EC Han, C Choi*
PLoS ONE 8 (7), e67891, 2013
|Vascular proteomics reveal novel proteins involved in SMC phenotypic change: OLR1 as a SMC receptor regulating proliferation and inflammatory response|
DH Kang*, M Choi, S Chang, MY Lee, DJ Lee, K Choi, J Park, EC Han, ...
PLoS ONE 10 (8), e0133845, 2015
|Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma|
J Park, CG Kim, JK Shim, JH Kim, H Lee, JE Lee, MH Kim, K Haam, I Jung, ...
OncoImmunology 8 (1), e1525243, 2019